Ajoy Bardhan

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Unlocking the potential: m6A-RNA methylation in severe epidermolysis bullosa simplex.

Unlocking the potential: m6A-RNA methylation in severe epidermolysis bullosa simplex.

Journal: Bioscience reports

Published: January 31, 2025

Optimisation of cutaneous microbiota sampling methodology.

Optimisation of cutaneous microbiota sampling methodology.

Journal: Frontiers in microbiomes

Published: January 13, 2025

Enamel Phenotype in Junctional Epidermolysis Bullosa.

Enamel Phenotype in Junctional Epidermolysis Bullosa.

Journal: The Journal of investigative dermatology

Published: November 26, 2024

Findings of the British Association of Dermatologists career survey of dermatologists in training and new consultant dermatologists 2023.

Findings of the British Association of Dermatologists career survey of dermatologists in training and new consultant dermatologists 2023.

Journal: Clinical and experimental dermatology

Published: July 01, 2024

Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.

Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.

Journal: The Journal of investigative dermatology

Published: May 18, 2023

Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?

Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?

Journal: Clinical and experimental dermatology

Published: February 11, 2023

IgA nephropathy in adults with epidermolysis bullosa.

IgA nephropathy in adults with epidermolysis bullosa.

Journal: Clinical and experimental dermatology

Published: August 22, 2022

Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa.

Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa.

Journal: Clinical and experimental dermatology

Published: April 12, 2022

The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database.

The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database.

Journal: The British journal of dermatology

Published: August 07, 2021

Localized autosomal recessive epidermolysis bullosa simplex arising from a novel homozygous frameshift mutation in DST (BPAG1).

Localized autosomal recessive epidermolysis bullosa simplex arising from a novel homozygous frameshift mutation in DST (BPAG1).

Journal: Clinical and experimental dermatology

Published: August 03, 2021

Toxic erythema as the first sign of COVID-19 infection.

Toxic erythema as the first sign of COVID-19 infection.

Journal: Clinical and experimental dermatology

Published: January 18, 2021

Epidermolysis bullosa.

Epidermolysis bullosa.

Journal: Nature reviews. Disease primers

Published: August 10, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026